Lloyd Rowland was Appointed as Senior Vice President and General Counsel at CytomX

Date of management change: June 14, 2018 

What Happened?

South San Francisco, -based CytomX Appointed Lloyd Rowland as Senior Vice President and General Counsel


About the Company

CytomX Therapeutics is a clinical-stage biopharmaceutical company with a deep and differentiated oncology pipeline of investigational Probody™ therapeutics. Probody therapeutics are designed to exploit unique conditions of the tumor microenvironment to more effectively localize antibody binding and activity while limiting activity in healthy tissues. The Company`s pipeline includes proprietary cancer immunotherapies against clinically-validated targets, such as PD-L1, and first-in-class Probody drug conjugates against highly attractive targets, such as CD166 and CD71, which are considered to be inaccessible to conventional antibody drug conjugates due to their presence on healthy tissue. In addition to its wholly owned programs, CytomX has strategic collaborations with AbbVie, Amgen, Bristol-Myers Squibb Company, MD Anderson Cancer Center and ImmunoGen, Inc.


About the Person

Lloyd Rowland is Senior Vice President and General Counsel at CytomX. Previously, Lloyd held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Grgurovic Allen, George Jeffrey, Myers Rebecca, Colman Christopher, Masters Bernard, Antlake Nora, Blatt Greg, Lynaugh Kathleen, Dekle Christopher, Ervin Jennifer, Murphy Anne

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.